SLC2A1 and neoplasm: LHDA and GLUT1 are key proteins in the glycolysis cascade for tumor metabolism since cancer cells require high glycolytic rates and have become potential targets in cancer treatments by inhibiting cell proliferation and inducing apoptosis40,41.